LexisNexis® Legal Newsroom
Abbott, B. Braun, Boehringer Ingelheim Settle Drug-Pricing Cases For $421M

BOSTON -- (Mealey's) Drug and medical supply makers Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories (now known as Boehringer Ingelheim Roxane Inc.) have agreed to pay a total of $421 million to settle False Claims Act allegations that they published inflated prices and caused...